A drug with the SMILES CN(c1ccc(Br)cc1)S(=O)(=O)c1ccc2[nH]cc(C(=O)NCCN3CCOCC3)c(=O)c2c1 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of -1.614\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CN(c1ccc(Br)cc1)S(=O)(=O)c1ccc2[nH]cc(C(=O)NCCN3CCOCC3)c(=O)c2c1
CN(c1ccc(Br)cc1)S(=O)(=O)c1ccc2[nH]cc(C(=O)NCCN3CCOCC3)c(=O)c2c1
6-[(4-bromophenyl)-methylsulfamoyl]-N-(2-morpholin-4-ylethyl)-4-oxo-1H-quinoline-3-carboxamide